Aloys L.
- Country
- Germany
- Department
- not applicable
Research Overview
Data & Insights
Has run more than one trial at 0 of 4 partner sites.
Specializations
Intravesical Therapy for Superficial Bladder Cancer
Focus on direct intravesical administration for Superficial Bladder Cancer.
- Intravesical mistletoe extract
- Recurrence prevention
- Local treatment strategies
Emphasis on local bladder therapy to delay tumor recurrence.
Combination CDK4/6 Inhibition in Metastatic Hormone-Sensitive Prostate Cancer
Evaluation of a CDK4/6 inhibitor combined with Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
- CDK4/6 inhibition
- Androgen pathway blockade
- Radiographic progression-free survival
Targeting cell‑cycle regulation to improve survival outcomes.
Novel Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer
Investigation of ASP5541 with and without steroids in Metastatic Castration-Resistant Prostate Cancer.
- ASP5541 efficacy
- Steroid-sparing regimens
- Androgen receptor pathway inhibition
Focus on resistant disease mechanisms and treatment sequencing.
Therapeutic Strategies for High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Therapeutic strategies for High-Risk Metastatic Hormone-Sensitive Prostate Cancer emphasizing hormonal optimization.
- Hormonal treatment optimization
- High-risk disease management
- Survival benefit
Integration of novel agents to enhance clinical outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.